CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 75 of 91 entries

View as:

Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema

Phase: N/A Priority: Normal

NCT ID: NCT01787669 Org: User:

Start: 06/30/13 End: 10/31/17 Due: 10/31/18

Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM

Phase: N/A Priority: Normal

NCT ID: NCT04195139 Org: User:

Start: 02/22/18 End: 12/31/25 Due: 12/31/26

Spacing Lidcombe Program Clinic Visits

Phase: N/A Priority: Normal

NCT ID: NCT00680303 Org: User:

Start: 01/31/08 End: 12/31/10 Due: 12/31/11

Adding Mitomycin to BCG as Adjuvant Intravesical Therapy for High-risk Non-Muscle-invasive Bladder Cancer

Phase: N/A Priority: Normal

NCT ID: NCT02948543 Org: User:

Start: 07/31/13 End: 12/31/24 Due: 12/31/25

Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours

Phase: N/A Priority: Normal

NCT ID: NCT02582697 Org: User:

Start: 02/28/14 End: 12/31/29 Due: 12/31/30

The Safety and Immunogenicity of a DNA-based Vaccine (COVIGEN) in Healthy Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT04742842 Org: User:

Start: 06/21/21 End: 07/30/23 Due: 07/30/24

Patient-led Surveillance Compared to Clinician-led Surveillance in People Treated for Localised Melanoma.

Phase: N/A Priority: Normal

NCT ID: NCT03581188 Org: User:

Start: 11/01/18 End: 02/17/20 Due: 02/17/21

The FREEDOM Study: a Randomised Controlled Trial of Sunlight and Calcium in Older People

Phase: N/A Priority: Normal

NCT ID: NCT00322166 Org: User:

Start: 07/31/06 End: 12/31/08 Due: 12/31/09

Intravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema That Persists After Laser Treatment (TDMO)

Phase: N/A Priority: Normal

NCT ID: NCT00167518 Org: User:

Start: 03/31/02 End: 04/30/05 Due: 04/30/06

Trial of Methoxyflurane With Periprostatic Local Anaesthesia to Reduce the Discomfort of TRUS B

Phase: N/A Priority: Normal

NCT ID: NCT02604225 Org: User:

Start: 12/31/15 End: 12/30/19 Due: 12/30/20

Chemotherapy Followed by Infusion of Partially HLA Matched Unrelated Donor Cells for Patients With AML Who Are Ineligible for Stem Cell Transplantation

Phase: N/A Priority: Normal

NCT ID: NCT02189824 Org: User:

Start: 08/31/14 End: - Due: -

PAEAN - Erythropoietin for Hypoxic Ischaemic Encephalopathy in Newborns

Phase: N/A Priority: Normal

NCT ID: NCT03079167 Org: User:

Start: 05/14/16 End: 04/30/24 Due: 04/30/25

A Multicentre Randomised Clinical Trial of Laser Treatment Plus Intravitreal Triamcinolone for Diabetic Macular Oedema

Phase: N/A Priority: Normal

NCT ID: NCT00148265 Org: User:

Start: 04/30/05 End: 05/31/09 Due: 05/31/10

Orthostatic Tolerance During FES (Functional Electrical Stimulation)-Walking in Paraplegia

Phase: N/A Priority: Normal

NCT ID: NCT00108043 Org: User:

Start: 03/31/04 End: 12/31/06 Due: 12/31/07

Surface Monitoring Technology to Remove The Mask - Stage 1

Phase: N/A Priority: Normal

NCT ID: NCT04266223 Org: User:

Start: 03/28/23 End: 12/31/24 Due: 12/31/25

Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX Study

Phase: N/A Priority: Normal

NCT ID: NCT00148330 Org: User:

Start: 05/31/05 End: 07/31/08 Due: 07/31/09

PBWST (Partial Body-Weight Supported Treadmill Training) and Muscle Power Training After Sub-acute Stroke

Phase: N/A Priority: Normal

NCT ID: NCT00108030 Org: User:

Start: 03/31/04 End: 12/31/06 Due: 12/31/07

Adaptive CT Acquisition for Personalised Thoracic Imaging

Phase: N/A Priority: Normal

NCT ID: NCT04070586 Org: User:

Start: 08/21/19 End: 02/19/21 Due: 02/19/22

MDMA-assisted Prolonged Exposure Therapy for Comorbid Alcohol Use Disorder and Post-traumatic Stress Disorder

Phase: N/A Priority: Normal

NCT ID: NCT05709353 Org: User:

Start: 09/19/23 End: 05/31/26 Due: 05/31/27

Follow-up of Children After Stuttering Treatment

Phase: N/A Priority: Normal

NCT ID: NCT00709072 Org: User:

Start: 02/28/09 End: 12/31/11 Due: 12/31/12

Herpes Zoster Vaccine for Bone Marrow Transplant Donors

Phase: N/A Priority: Normal

NCT ID: NCT01573182 Org: User:

Start: 04/30/12 End: 05/03/18 Due: 05/03/19

Collection of Head Images During Radiotherapy

Phase: N/A Priority: Normal

NCT ID: NCT05218824 Org: User:

Start: 02/14/22 End: 12/31/24 Due: 12/31/25

Post-Operative Prediction of PulmonarY Function

Phase: N/A Priority: Normal

NCT ID: NCT06494254 Org: User:

Start: 07/31/24 End: 12/31/25 Due: 12/31/26

Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transplantation

Phase: N/A Priority: Normal

NCT ID: NCT02779439 Org: User:

Start: 01/31/13 End: 03/31/18 Due: 03/31/19

Australian Screening Mammography Decision Aid Trial: A Decision Aid for Women Aged 40 Thinking About Starting Mammography Screening

Phase: N/A Priority: Normal

NCT ID: NCT00139048 Org: User:

Start: 09/30/05 End: 02/28/07 Due: 02/28/08

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema	NCT01787669	University of Sydney	user2@example.com	None	2013-06-30	2017-10-31	2018-10-31	-	-	2025-07-14
Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM	NCT04195139	University of Sydney	user2@example.com	None	2018-02-22	2025-12-31	2026-12-31	-	-	2025-07-14
Spacing Lidcombe Program Clinic Visits	NCT00680303	University of Sydney	user2@example.com	None	2008-01-31	2010-12-31	2011-12-31	-	-	2025-07-14
Adding Mitomycin to BCG as Adjuvant Intravesical Therapy for High-risk Non-Muscle-invasive Bladder Cancer	NCT02948543	University of Sydney	user2@example.com	None	2013-07-31	2024-12-31	2025-12-31	-	-	2025-07-14
Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours	NCT02582697	University of Sydney	user2@example.com	None	2014-02-28	2029-12-31	2030-12-31	-	-	2025-07-14
The Safety and Immunogenicity of a DNA-based Vaccine (COVIGEN) in Healthy Volunteers	NCT04742842	University of Sydney	user2@example.com	None	2021-06-21	2023-07-30	2024-07-30	-	-	2025-07-14
Patient-led Surveillance Compared to Clinician-led Surveillance in People Treated for Localised Melanoma.	NCT03581188	University of Sydney	user2@example.com	None	2018-11-01	2020-02-17	2021-02-17	-	-	2025-07-14
The FREEDOM Study: a Randomised Controlled Trial of Sunlight and Calcium in Older People	NCT00322166	University of Sydney	user2@example.com	None	2006-07-31	2008-12-31	2009-12-31	-	-	2025-07-14
Intravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema That Persists After Laser Treatment (TDMO)	NCT00167518	University of Sydney	user2@example.com	None	2002-03-31	2005-04-30	2006-04-30	-	-	2025-07-14
Trial of Methoxyflurane With Periprostatic Local Anaesthesia to Reduce the Discomfort of TRUS B	NCT02604225	University of Sydney	user2@example.com	None	2015-12-31	2019-12-30	2020-12-30	-	-	2025-07-14
Chemotherapy Followed by Infusion of Partially HLA Matched Unrelated Donor Cells for Patients With AML Who Are Ineligible for Stem Cell Transplantation	NCT02189824	University of Sydney	user2@example.com	None	2014-08-31	-	-	-	-	2025-07-14
PAEAN - Erythropoietin for Hypoxic Ischaemic Encephalopathy in Newborns	NCT03079167	University of Sydney	user2@example.com	None	2016-05-14	2024-04-30	2025-04-30	-	-	2025-07-14
A Multicentre Randomised Clinical Trial of Laser Treatment Plus Intravitreal Triamcinolone for Diabetic Macular Oedema	NCT00148265	University of Sydney	user2@example.com	None	2005-04-30	2009-05-31	2010-05-31	-	-	2025-07-14
Orthostatic Tolerance During FES (Functional Electrical Stimulation)-Walking in Paraplegia	NCT00108043	University of Sydney	user2@example.com	None	2004-03-31	2006-12-31	2007-12-31	-	-	2025-07-14
Surface Monitoring Technology to Remove The Mask - Stage 1	NCT04266223	University of Sydney	user2@example.com	None	2023-03-28	2024-12-31	2025-12-31	-	-	2025-07-14
Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX Study	NCT00148330	University of Sydney	user2@example.com	None	2005-05-31	2008-07-31	2009-07-31	-	-	2025-07-14
PBWST (Partial Body-Weight Supported Treadmill Training) and Muscle Power Training After Sub-acute Stroke	NCT00108030	University of Sydney	user2@example.com	None	2004-03-31	2006-12-31	2007-12-31	-	-	2025-07-14
Adaptive CT Acquisition for Personalised Thoracic Imaging	NCT04070586	University of Sydney	user2@example.com	None	2019-08-21	2021-02-19	2022-02-19	-	-	2025-07-14
MDMA-assisted Prolonged Exposure Therapy for Comorbid Alcohol Use Disorder and Post-traumatic Stress Disorder	NCT05709353	University of Sydney	user2@example.com	None	2023-09-19	2026-05-31	2027-05-31	-	-	2025-07-14
Follow-up of Children After Stuttering Treatment	NCT00709072	University of Sydney	user2@example.com	None	2009-02-28	2011-12-31	2012-12-31	-	-	2025-07-14
Herpes Zoster Vaccine for Bone Marrow Transplant Donors	NCT01573182	University of Sydney	user2@example.com	None	2012-04-30	2018-05-03	2019-05-03	-	-	2025-07-14
Collection of Head Images During Radiotherapy	NCT05218824	University of Sydney	user2@example.com	None	2022-02-14	2024-12-31	2025-12-31	-	-	2025-07-14
Post-Operative Prediction of PulmonarY Function	NCT06494254	University of Sydney	user2@example.com	None	2024-07-31	2025-12-31	2026-12-31	-	-	2025-07-14
Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transplantation	NCT02779439	University of Sydney	user2@example.com	None	2013-01-31	2018-03-31	2019-03-31	-	-	2025-07-14
Australian Screening Mammography Decision Aid Trial: A Decision Aid for Women Aged 40 Thinking About Starting Mammography Screening	NCT00139048	University of Sydney	user2@example.com	None	2005-09-30	2007-02-28	2008-02-28	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance